European community pharmacists practice in tackling influenza

IF 1.8 Q3 PHARMACOLOGY & PHARMACY Exploratory research in clinical and social pharmacy Pub Date : 2024-04-22 DOI:10.1016/j.rcsop.2024.100447
Marleen Haems , Mauro Lanzilotto , Andrea Mandelli , Hélder Mota-Filipe , Ema Paulino , Beata Plewka , Olivier Rozaire , Jens Zeiger
{"title":"European community pharmacists practice in tackling influenza","authors":"Marleen Haems ,&nbsp;Mauro Lanzilotto ,&nbsp;Andrea Mandelli ,&nbsp;Hélder Mota-Filipe ,&nbsp;Ema Paulino ,&nbsp;Beata Plewka ,&nbsp;Olivier Rozaire ,&nbsp;Jens Zeiger","doi":"10.1016/j.rcsop.2024.100447","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>In many European countries, flu vaccination coverage rates are below the 75% target. During the COVID-19 pandemic, many pharmacists around Europe were involved as vaccine administrators and demonstrated positive results in improving vaccine uptake. This paper explores the challenges, accomplishments, and best practices of various European pharmacists' associations in administering vaccines and positively contributing to public health.</p></div><div><h3>Methods</h3><p>Eight pharmacists representing various associations from different countries across Europe (Italy, Belgium, Poland, Portugal, France, and Germany) convened to discuss their role as vaccination providers, the advantages, and strategies for improvement, and to identify barriers and gaps in the vaccination administration process, especially focusing on the administration of seasonal flu vaccines.</p></div><div><h3>Results</h3><p>Currently, 15 European countries allow community pharmacists to dispense and administer flu vaccines. Among the ones that attended the meeting, Portugal initiated the flu immunization program at the pharmacy earliest, before the COVID era, but in other countries, the process started only in the last couple of years. Initial hesitancy and reluctance by other HCPs or institutions were overcome as the pilot projects showed positive and cost-effective public health results. Today, pharmacists are considered crucial professional figures to provide immunization services against COVID-19, the flu, and other vaccine-preventable diseases, and pursue important public health goals.</p><p>Key takeaways to enhance the pharmacist's role in providing immunization services against vaccine-preventable diseases include improving interaction with policymakers and the public, generating real-world evidence highlighting public health benefits, and ensuring ongoing professional education and training for pharmacists.</p></div><div><h3>Conclusion</h3><p>Vaccinating pharmacists are gaining recognition of their role and the benefits derived from their broader involvement in the healthcare system, including immunization programs. Further efforts are needed in each country for an adequate recognition of the profession and a broader utilization of pharmacy services to exploit the benefit of immunization, especially against the flu.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266727662400043X/pdfft?md5=64bd1572ab2acc2c60e42d64b65be56d&pid=1-s2.0-S266727662400043X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploratory research in clinical and social pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266727662400043X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

In many European countries, flu vaccination coverage rates are below the 75% target. During the COVID-19 pandemic, many pharmacists around Europe were involved as vaccine administrators and demonstrated positive results in improving vaccine uptake. This paper explores the challenges, accomplishments, and best practices of various European pharmacists' associations in administering vaccines and positively contributing to public health.

Methods

Eight pharmacists representing various associations from different countries across Europe (Italy, Belgium, Poland, Portugal, France, and Germany) convened to discuss their role as vaccination providers, the advantages, and strategies for improvement, and to identify barriers and gaps in the vaccination administration process, especially focusing on the administration of seasonal flu vaccines.

Results

Currently, 15 European countries allow community pharmacists to dispense and administer flu vaccines. Among the ones that attended the meeting, Portugal initiated the flu immunization program at the pharmacy earliest, before the COVID era, but in other countries, the process started only in the last couple of years. Initial hesitancy and reluctance by other HCPs or institutions were overcome as the pilot projects showed positive and cost-effective public health results. Today, pharmacists are considered crucial professional figures to provide immunization services against COVID-19, the flu, and other vaccine-preventable diseases, and pursue important public health goals.

Key takeaways to enhance the pharmacist's role in providing immunization services against vaccine-preventable diseases include improving interaction with policymakers and the public, generating real-world evidence highlighting public health benefits, and ensuring ongoing professional education and training for pharmacists.

Conclusion

Vaccinating pharmacists are gaining recognition of their role and the benefits derived from their broader involvement in the healthcare system, including immunization programs. Further efforts are needed in each country for an adequate recognition of the profession and a broader utilization of pharmacy services to exploit the benefit of immunization, especially against the flu.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
欧洲社区药剂师应对流感的实践
背景在许多欧洲国家,流感疫苗接种率低于 75% 的目标。在 COVID-19 大流行期间,欧洲的许多药剂师作为疫苗管理者参与其中,并在提高疫苗接种率方面取得了积极成果。方法来自欧洲不同国家(意大利、比利时、波兰、葡萄牙、法国和德国)的八位药剂师代表不同的协会召开会议,讨论他们作为疫苗接种提供者的角色、优势和改进策略,并找出疫苗接种管理过程中的障碍和差距,尤其关注季节性流感疫苗的接种。在参加会议的国家中,葡萄牙在 COVID 时代之前最早在药房启动了流感免疫计划,而其他国家则在最近几年才开始这一进程。随着试点项目显示出积极和具有成本效益的公共卫生成果,其他 HCP 或机构最初的犹豫和不情愿都被克服了。如今,药剂师被认为是提供针对 COVID-19、流感和其他疫苗可预防疾病的免疫服务的重要专业人士,并致力于实现重要的公共卫生目标。加强药剂师在提供针对疫苗可预防疾病的免疫接种服务中的作用的主要启示包括:改善与政策制定者和公众的互动,生成突出公共卫生益处的真实证据,以及确保对药剂师进行持续的专业教育和培训。每个国家都需要进一步努力,以充分认可药剂师这一职业,并更广泛地利用药剂服务来发挥免疫接种(尤其是预防流感)的益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
0
审稿时长
103 days
期刊最新文献
Montelukast deprescribing in outpatient specialty clinics: A single center cross-sectional study Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation at a tertiary care hospital in Thailand Comparing nursing medication rounds before and after implementation of automated dispensing cabinets: A time and motion study Translation, transcultural adaptation, and validation of the Brazilian Portuguese version of the general medication adherence scale (GMAS) in patients with high blood pressure A cross-sectional survey exploring organizational readiness to implement community pharmacy-based opioid counseling and naloxone services in rural versus urban settings in Alabama
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1